<DOC>
	<DOCNO>NCT00949130</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety oral NXL103 vs. establish treatment acute bacterial infection adult .</brief_summary>
	<brief_title>Comparative Study NXL103 Versus Linezolid Adults With Acute Bacterial Skin Skin Structure Infections ( ABSSSI )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Streptogramin A</mesh_term>
	<criteria>Diagnosed acute bacterial skin skin structure infection ( ABSSSI ) least 3 sign symptom Uncomplicated acute bacterial skin skin structure infection ABSSSI suspect proven due Gram negative and/or anaerobic pathogen Pregnant lactate woman Inadequately control diabetes mellitus Inadequately control arterial hypertension Moderatetosevere renal impairment Moderatetosevere liver disease Conditions associate immunodeficiency Known hypersensitivity contraindication use 2 study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>